Volume 70, Issue 6, December 2012

ISSN: 0344-5704 (Print) 1432-0843 (Online)

In this issue (14 articles)

  1. No Access

    Review Article

    High-dose etoposide in allogeneic stem cell transplantation

    Øystein Bruserud, Håkon Reikvam… Pages 765-782
    Look Inside Get Access

  2. No Access

    Original Article

    Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer

    Takayuki Shiroyama, Takashi Kijima, Kiyoshi Komuta… Pages 783-789
    Look Inside Get Access

  3. No Access

    Original Article

    Phase I study of nelfinavir in liposarcoma

    Janet Pan, Michelle Mott, Bixin Xi… Pages 791-799
    Look Inside Get Access

  4. No Access

    Original Article

    Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro

    Chongmei Huang, Xiaoxia Hu, Libing Wang, Shuqing Lü… Pages 801-809
    Look Inside Get Access

  5. No Access

    Original Article

    Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models

    Daniela Meco, Angela Maria Di Francesco… Pages 811-822
    Look Inside Get Access

  6. No Access

    Original Article

    Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment

    L. A. Devriese, P. O. Witteveen, S. Marchetti… Pages 823-832
    Look Inside Get Access

  7. No Access

    Original Article

    6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation

    Wesam M. El-Bakly, Manal L. Louka… Pages 833-841
    Look Inside Get Access

  8. No Access

    Original Article

    A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy

    Michael J. Pishvaian, Rebecca Slack, Eunice Y. Koh… Pages 843-853
    Look Inside Get Access

  9. No Access

    Original Article

    Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas

    Rinat Bernstein-Molho, Yehuda Kollender… Pages 855-860
    Look Inside Get Access

  10. No Access

    Original Article

    Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials

    Man-Tang Qiu, Xiang-Xiang Ding, Jing-Wen Hu… Pages 861-873
    Look Inside Get Access

  11. No Access

    Original Article

    A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer

    Andrew H. Ko, Thach-Giao Truong, Emily Kantoff… Pages 875-881
    Look Inside Get Access

  12. No Access

    Original Article

    Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer

    M. Provencio, C. Camps, M. Cobo, R. De las Peñas… Pages 883-890
    Look Inside Get Access

  13. No Access

    Clinical Trial Report

    Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies

    Da Zhang, Monica Mita, Geoffrey I. Shapiro… Pages 891-898
    Look Inside Get Access

  14. No Access

    Short Communication

    Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer

    Marta Lucchetta, Sara Lonardi, Francesca Bergamo… Pages 899-902
    Look Inside Get Access